Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation

被引:240
作者
Ahsan, H
Chen, Y
Parvez, F
Argos, M
Hussain, AI
Momotaj, H
Levy, D
Van Geen, A
Geoffrey, HA
Graziano, J
机构
[1] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10032 USA
[3] Natl Inst Prevent & Social Med, Dhaka, Bangladesh
[4] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY 10032 USA
[5] Columbia Univ, Lamont Doherty Earth Observ, New York, NY 10032 USA
[6] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
关键词
arsenic exposure; Bangladesh; environmental epidemiology; cohort study;
D O I
10.1038/sj.jea.7500449
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Health Effects of Arsenic Longitudinal Study ( HEALS), a multidisciplinary and large prospective cohort study in Araihazar, Bangladesh, was established to evaluate the effects of full-dose range arsenic ( As) exposure on various health outcomes, including premalignant and malignant skin tumors, total mortality, pregnancy outcomes, and children's cognitive development. In this paper, we provide descriptions of the study methods including study design, study population, data collection, response rates, and exposure and outcome assessments. We also present characteristics of the study participants including the distribution of exposure and the prevalence of skin lesion at baseline recruitment. A total of 11,746 marriedmen and women between 18 and 75 years of age participated in the study at baseline ( a response rate of 98%) and completed a full questionnaire interview that included a food frequency questionnaire, with a response rate of 98%. Among the 98% of the participants who completed the clinical evaluation, over 90% provided blood samples and spot urine samples. Higher educational status, male gender, and presence of premalignant skin lesions were associated with an increased likelihood of providing blood and urine samples. Older participants were less likely to donate a blood sample. About one-third of the participants consumed water from a well with As concentration in each of three groups: > 100 mu g/l, 25-100 mu g/l, and < 25 mu g/l. Average urinary As concentrations were 140 and 136 mu g/l for males and females, respectively. HEALS has several unique features, including a prospective study design, comprehensive assessments of both past and future changes in As exposure at the individual level, a large repository of biological samples, and a full dose range of As exposures in the study population. HEALS is a valuable resource for examining novel research questions on the health effects of As exposure.
引用
收藏
页码:191 / 205
页数:15
相关论文
共 39 条
  • [1] Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh
    Ahsan, H
    Perrin, M
    Rahman, A
    Parvez, F
    Stute, M
    Zheng, Y
    Milton, AH
    Brandt-Rauf, P
    van Geen, A
    Graziano, J
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2000, 42 (12) : 1195 - 1201
  • [2] CHRONIC ARSENIC TOXICITY
    ALAIN, G
    TOUSIGNANT, J
    ROZENFARB, E
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (12) : 899 - 901
  • [3] Arsenic poisoning in groundwater - Health risk and geochemical sources in Bangladesh
    Anawar, HM
    Akai, J
    Mostofa, KMG
    Safiullah, S
    Tareq, SM
    [J]. ENVIRONMENT INTERNATIONAL, 2002, 27 (07) : 597 - 604
  • [4] [Anonymous], 2000, EPA815R00023
  • [5] *BRIT GEOL SURV, 1999, GROUNDW STUD ARS CON
  • [6] A DOSE-RESPONSE ANALYSIS OF SKIN-CANCER FROM INORGANIC ARSENIC IN DRINKING-WATER
    BROWN, KG
    BOYLE, KE
    CHEN, CW
    GIBB, HJ
    [J]. RISK ANALYSIS, 1989, 9 (04) : 519 - 528
  • [7] Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic
    Buchet, JP
    Lison, D
    [J]. INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 1998, 71 (02) : 125 - 130
  • [8] CHAKRABORTY AK, 1987, INDIAN J MED RES, V85, P326
  • [9] CHEN CJ, 1985, CANCER RES, V45, P5895
  • [10] CHEN CJ, 1990, CANCER RES, V50, P5470